High circulating levels of cholesterol, particularly low density lipoprotein (LDL) cholesterol and the clotting factors fibrinogen and factor VII, are associated with increased risk of myocardial infarction. Variations in the plasma levels of these factors are determined in part by polymorphisms in the genes concerned and also by weight at 1 year (infant weight). We have looked at the possibility of interactions between these genetic factors and infant weight in a sample of 290 men and 192 women from Hertfordshire using the ,-fibrinogen GIA-455, factor VII R353Q, and ApoE polymorphisms. The rare allele frequencies of the three polymorphisms were 0.19 for P-fibrinogen, 0.10 for factor VII, and 0.07 and 0.13 for the 2 and 4 alleles of ApoE, and these frequencies were not different in subjects of different infant weight. In this sample, the polymorphisms showed the expected effects on plasma levels of fibrinogen, factor VII, and LDL cholesterol. The A-455 allele was associated with higher fibrinogen levels but the effect was only statistically significant in women (p=0.003). The R353 allele was associated with higher factor VII activity in both men and women (p<O.OOOl for both). The ApoE2 allele was associated with lower levels of LDL cholesterol (p=0.03 in men, p=0.006 in women), while the ApoE4 allele was associated with higher levels (p<0.001 in men, not significant in women). In this sample of men and women the effect of low infant weight was only associated with significant effects on fibrinogen and LDL cholesterol in the group of men (p=0.005 and p=0.008 respectively). Compared with the E3E3 subjects, the LDL lowering effect of the E2 allele and the raising effect of the E4 allele was greater in those with low infant weight compared with those with high infant weight (low v high infant weight for E2: 12.7% v 9.4%; for E4 12.7% v 8.5%). Although in this sample the interactive effect did not reach statistical significance, the additive effect of ApoE genotype and low infant weight on determining plasma LDL cholesterol levels, if confirmed, may be of relevance in determining a person's future risk of atherosclerosis.
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(JMed Genet 1997;34:553-558) Keywords: fibrinogen; factor VII; ApoE polymorphisms; infant weight While the effects of both genetic and environmental influences on risk of coronary heart disease are well known individually, the extent to which they interact has not been characterised. Raised plasma concentrations of fibrinogen, factor VII, and total cholesterol are associated with increased risk of coronary heart disease in men.' They predispose to thrombosis and contribute to the development and progression of atheroma.
Recently, coronary heart disease and its risk factors, hypertension, non-insulin dependent diabetes, and abnormalities in lipid metabolism and blood coagulation, have been shown to be associated with small size at birth and low weight gain during infancy.2" These associations are independent of adult lifestyle, including smoking, obesity, and social class, and have led to the conclusion that the disease is "programmed" in utero. The "fetal origins hypothesis" proposes that adaptations made by the fetus in response to undernutrition lead to persisting changes in metabolism and organ structure. There is experimental support for this hypothesis, since if pregnant animals are undernourished their offspring show permanent changes, including raised blood pressure and altered glucose-insulin and lipid metabolism."-The first direct evidence that coronary heart disease was associated with low growth rates in utero and during infancy came from studies of 16 000 men and women who were born in the county of Hertfordshire between 1911 and 1930 and were traced from birth to the present day.2 8 Death rates from coronary heart disease fell progressively between those who weighed less than 5.5 pounds (2500 g) at birth and those who were more than 9.5 pounds (4310 g). In men, but not women, there was also a strong association with low weight at 1 year of age. A series of studies examined the prevalence of coronary risk factors in relation to early weight. Among men, plasma fibrinogen and factor VII concentrations fell with increasing weight at 1 year (infant weight).' There were no similar associations in women.'0 It was suggested that the associations in men are a persisting response to impaired liver development during a critical early period. Subsequent studies have provided further evidence for this." shown to have higher levels of plasma fibrinogen than heterozygotes, having levels intermediate to G-4" homozygotes, who have the lowest levels.
Factor VII is also secreted from the liver and acts as part of the extrinsic coagulation pathway. The factor VII polymorphism causes an arginine to glutamine amino acid change at residue 353 (R353Q).'6 17 The common R353 allele is associated with significantly higher factor VIIc levels in several sample groups."821 Apolipoprotein E is a protein of 229 residues important in lipoprotein metabolism. 22 There are three isoforms E2, E3, and E4 encoded by alleles &2, 03, and A4 respectively, which differ by amino acid residues at positions 112 and 158. The E2 isoform comprises cysteine residues at both positions, E4 has two arginine residues, and E3, the most common form, has Cys at position 112 and Arg at 158. The E4 allele has been associated with coronary artery disease and raised levels of plasma lipids.2225 under-Materials and methods Taluable PATIENT RESOURCES le. We As previously described, all births in Hertford-., factor shire from 1911 onwards were notified by the L.1) and attending midwife. Table 2 The rare allele frequencies of three polymorphisms by thirds of infant weight (1 y).
Confidence intervals (95%) are given in parentheses with the frequencies. The association between genotypes and plasma traits was examined in men and women separately. For all polymorphisms, because of the low number of subjects homozygous for the rare alleles, comparisons were made between those homozygous for the common allele and those carrying one or more copies of the rare allele. The effect associated with genotype on fibrinogen levels in men was small (table 3A) , and in comparison with the common homozygote group (genotype G/G-455), those with one or more A alleles had a non-significant difference of -1.0% (3 mg/dl). In women (table 3B) there was a much larger effect of +7.6% (22 mg/dl, p=0.003). Greater differences in plasma fibrinogen across infant weight groups were observed in men than women, with levels 7.7% higher in the low than the high infant weight groups (22 mg/dl, p=0.005) but only +3.8% in women (11 mg/dl, not significant). Comparing the effect of genotype in the thirds of infant weight, the difference between the fibrinogen levels of the lowest and highest risk groups (as predicted from previous studies, that is, low infant weight and an A allele present versus GG subjects who had high infant weight) is 27 mg/dl in men and 23 mg/dl in women, increases of 9.6% and 8.2% respectively.
The effects of factor VII genotype and infant weight on factor VII activity were more similar between men and women than for fibrinogen (table 4) although the actual activities were significantly different (p<0.001). Male and female differences in factor VII coagulant activity levels between the common homozygote and subjects with a Q allele were 34.5% and 30.8% fig 2) . Compared to the E3E3 group the overall lowering effect of the E2 allele in men is 12.4% (0.58 mmol/l, p=0.025) and the E4 raising effect is 9.0% (0.42 mmol/l, p<0.001). The difference between high and low infant weight groups is +8.2% (0.37 mmol/l, p=0.008). In women (table 5B) there is a significant lowering effect of the E2 allele on LDL cholesterol levels (13.2%, p=0.006) compared with ApoE3E3 subjects. The raising effect of E4 (versus E3E3) and the effect of low infant weight are +1.6% and +0.4% respectively. The data for women do not show consistent relationships between LDL cholesterol and genotype or infant weight, which may be because of the power being limited by the smaller numbers involved. However, even in the men, regression analysis failed to show evidence for any statistically significant interactions between infant weight and any of the polymorphisms examined.
The data were also examined with respect to the possible interaction between thirds of birth weight, genotype, and plasma levels of risk factors. As found for infant weight, birth weight was associated with statistically significant effects in men (p=0.008) but not in women, although the A allele raising effect was of similar magnitude in the lowest and highest birth weight groups (data not shown). For both factor VII and LDL cholesterol there was no significant effect associated with birth weight in this sample.
Discussion
We have analysed a sample of 290 men and 192 women for whom birth weight, infant weight, and lipid and clotting factor data were available, looking at fibrinogen, factor VII, and ApoE genotypes and weight at 1 year (infant weight). A priori we would expect the effect of alleles raising fibrinogen, factor VII, and LDL cholesterol to be additive with the effects of low infant weight rather than interactive. One way in which genotype might interact with low infant weight to predispose to high levels of a risk factor would be if the allele associated with increased levels of the trait were more frequent in infants in the low weight category. Our data show no support for this possibility. Allele frequencies in this sample were similar to those reported previously'2 16 22 and were not different in men or women with different birth weight (data not shown) or infant weight.
A second way genotype and infant weight would show interaction would be if the size of the raising effect associated with an allele was different in infants of different weights. A mechanistic explanation for this would be that changes in expression of the gene had been programmed by in utero nutritional events. A similar phenomenon has been seen in vitro where glucose induced fibronectin overexpression has remained many generations after glucose has been removed from the milieu, the fibronectin gene thought to have been permanently switched on by the initial glucose challenge. 29 In this small sample of men and women there was an association between infant weight and higher fibrinogen in men (p=0.005), no association between infant weight and factor VII levels in either gender, and an association with LDL cholesterol in men for both E2 and E4 alleles (p=0.008 for both). The fibrinogen A-455 allele was only associated with a significant raising effect in women (p=0.003) and the factor VII R353 allele was strongly associated with high factor VII activity in both men and women (p<0.001). The ApoE2 allele was associated with lower LDL cholesterol in men (p=0.008) and women (p=0.006) and the E4 allele was associated with higher LDL cholesterol in men (p=O.OOl).
For factor VII and ApoE, the magnitudes of the genotype associated effects in the whole group of men and women are similar to those reported previously. Those with one or more copies of the factor VII Q353 allele had levels lower by 30% in men and 33% in women, similar to the 25-30% lower levels previously reported in healthy men and women.' 2' For ApoE2 compared to the E3E3 group, the lowering effect associated with the ApoE2 genotype is 0.58 mmol/l in men and 0.68 mmol/l in women, and the raising effect associated with the ApoE4 genotype is 0.42 mmol/l in men, but only 0.08 mmol/l in women. In studies of healthy men and women of this age (64 years), ApoE2 lowering effects in the range 0.62-0.75 mmol/l and ApoE4 raising effects in the range 0.03-0.23 mmol/l have been reported.30 31 The 
